Weaver Gregory L's Form 4 filing
Atossa Therapeutics, Inc. (ATOS) · filed Jul 7, 2021
- Accession no.
- 0001437749-21-016573
- Filed
- Jul 7, 2021
- Trade date
- Jul 2, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $599.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weaver Gregory LCIK 0001251779 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Common Stock | MOption exerciseAcquired | +4,581 | $5.64 | +$25,836.84 | 4,581 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseAcquired | +45,000 | $2.38 | +$107,100 | 49,581 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseAcquired | +45,000 | $2.52 | +$113,400 | 94,581 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseAcquired | +70,000 | $1.70 | +$119,000 | 164,581 | Direct | |
| Jul 2, 2021 | Common Stock | FTax withholdingDisposed | −57,084 | $6.40 | −$365,337.6 | 107,497 | Direct | |
| Jul 2, 2021 | Common Stock | SSaleDisposed | −107,497 | $5.58 | −$599,833.26 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Common Stock | MOption exerciseDisposed | −4,581 | $0.00 | $0 | 0 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 0 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseDisposed | −45,000 | $0.00 | $0 | 0 | Direct | |
| Jul 2, 2021 | Common Stock | MOption exerciseDisposed | −70,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.